(NASDAQ: OPT) Opthea's forecast annual revenue growth rate of 461.95% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Opthea's revenue in 2024 is $385,275.On average, 3 Wall Street analysts forecast OPT's revenue for 2024 to be $107,913,815, with the lowest OPT revenue forecast at $46,715,937, and the highest OPT revenue forecast at $184,060,793. On average, 3 Wall Street analysts forecast OPT's revenue for 2025 to be $11,483,711,732, with the lowest OPT revenue forecast at $46,715,937, and the highest OPT revenue forecast at $23,357,968,700.
In 2026, OPT is forecast to generate $34,662,758,391 in revenue, with the lowest revenue forecast at $11,678,984,350 and the highest revenue forecast at $57,646,532,433.